Feature | September 07, 2010| Dave Fornell

Forward-Looking IVUS May Aid CTO Visualization

FL-IVUS has promise to help speed chronic total occlusion procedures

A major issue in treating chronic total occlusions (CTOs) is the lack of angiographic visualization. The flow of blood and contrast is completely blocked, eliminating the ability to navigate the vessel or see where wires are being poked. Not being able to see what you are treating is a big reason why operators do not attempt these lesions.

“All you see is the start and the end of the lesion. It can be very terrifying,” said William Lombardi, M.D., FSCAI, medical director of cardiac cath labs at St. Joseph Hospital, Bellingham, Wash.

In a comparison of items needed to treat CTOs, Scott Huennekens, president and CEO of Volcano Corp., said to build a car you need wheels, steering and headlights. There are already interventional tools available to steer and treat CTOs, but operators still need a way to see where they are driving. “You are always driving in the dark. You have wheels and steering, but you have no headlights, so you can’t see where you are going,” Huennekens said.

Volcano is developing two forward-looking intravascular ultrasound systems (FL-IVUS). One is for visualization ahead of the catheter and the second will incorporate a radio frequency (RF) ablation tip.

Aaron Grantham, M.D., FACC, Mid-America Heart Institute, Kansas City, Mo., is not convinced that incorporating the RF tip will completely solve CTO treatment issues. He said prior RF catheters were unsuccessful. However, he thinks FL-IVUS has the potential to make visualizing and traversing CTOs with wires easier and safer. He is very interested to hear reports about the first-in-man experience scheduled to start this fall in the Netherlands and Chile. “Translation from bench models to bedside will be a major milestone for FL-IVUS,” he said.

Volcano hopes for European CE-mark clearance of its FL-IVUS device by mid-2011, and in the U.S. by the end of 2011. The company said its first-in-man trial for the FL-IVUS ablation system is set to begin by mid-2011.

“In theory, forward-looking IVUS has promise. However, some operators already have a 95 percent success rate, so it will have to show it can do the procedure faster,” Lombardi said. “All technology is going to do is shorten the procedure.”

Related Content

Products | Intravascular Imaging| August 03, 2015
Pie Medical Imaging, CAAS IntraVascular 2.0, OCT, IVUS, NIRS-IVUS
Technology | Intravascular Imaging| August 03, 2015
Pie Medical Imaging announced the release of CAAS IntraVascular 2.0, the dedicated software for analysis of...
St. Jude Medical, OCT, ILUMIEN III, IVUS, angiography, PCI
Feature | Intravascular Imaging| July 10, 2015
St. Jude Medical, Inc. announced the launch of the ILUMIEN III clinical trial on June 30. ILUMIEN III is a prospective...
Ilumien Optis, 3D OCT, 3-D OCT

An OCT 3-D reconstructed image of a coronary vessel cutaway showing a stent and bifurcating vessels.

Feature | Intravascular Imaging| July 02, 2015 | Dave Fornell
Angiography alone for procedural image guidance in the catheterization lab is sometimes not enough, and it is helpful...
Cordis Corp., Cordis Crossing Portfolio, Elitecross, Outback Elite, CTO
Technology | June 10, 2015
Cordis Corp. announced the launch of the new Elitecross support catheter in the United States and Outback Elite re-...
Infraredx, LRP Study, TVC Imaging System, Lipid-Rich Plaques, 1,000 patients

The Infraredx system combines IVUS with spectroscopy, which shows a halo ring of color, with yellow being plaque and red representing lipid core plaques based on the chemical composition.

News | April 28, 2015
Infraredx Inc. announced the enrollment of 1,000 patients in the Lipid-Rich Plaque (LRP) Study. The LRP Study is a...
Videos | ACC| March 25, 2015
DAIC Editor Dave Fornell shares his picks of the most interesting new devices and advances in cardiovascular technolo
Infraredx, NIRS, IVUS, catheter, Advanced TVC Imaging System, ACC 15
News | March 13, 2015
Infraredx announced it will premiere the Advanced TVC Imaging System and the Muller NIRS-IVUS Catheter featuring...
near-infrared spectroscopy, NIRS, heart attack, stroke, Infraredx, TVC

Image courtesy of Infraredx

Feature | December 09, 2014
A study published in the Journal of the American College of Cardiology (JACC) shows intravascular near-infrared...
Technology | November 04, 2014
The U.S. Food and Drug Administration (FDA) has cleared the Abbott family of Xience everolimus-eluting coronary stents...
Overlay Init